TrialOrphanet journal of rare diseases2024

Long-term follow-up of givosiran treatment in patients with acute intermittent porphyria from a phase 1/2, 48-month open-label extension study.

Eliane Sardh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.